Highlights of ASH in the Mediterranean, Middle East, and North Africa
Save the Date!
Join the world's leading hematology experts at Highlights of ASH in the Mediterranean, Middle East, and North Africa, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.
April 4-5, 2025
Casablanca, Morocco
About Highlights of ASH in in the Mediterranean, Middle East, and North Africa
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Through participation in this meeting, you will be able to:
Access a program curated from highlights of the ASH annual meeting which covers the latest and most influential topics in hematology.
Engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
Program Co-Host
ASH is proud to co-host this meeting with the Société Marocaine d'Hématologie
Program Schedule
The following session topics corresponds to the 2025 Highlights of ASH in the Mediterranean, Middle East, and North Africa and is subject to change.
- Highlights in Aggressive Lymphoma
- Highlights in Indolent Lymphoma including Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Bi-Specifics: Toxicity and Management
- Supportive Care in Hematology
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Myeloproliferative Neoplasms
- Thrombosis
- Hemostasis and Other Bleeding Disorders
- Hemoglobinopathies including Sickle Cell Disease and Thalassemia
- Cellular Therapeutics
- Transfusion Medicine
- Challenges and Opportunities in Bringing CAR-T Cell Therapy to Africa